Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Gema Moreno-Bueno Josep Tabernero Caturla Joaquin Arribas Serena Di Cosimo |
| Publication date | October 1, 2004 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |